HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 338482Generated: October 29, 2026
Hydrochloric Acid → 6-Chloro-5-(4-(2-hydroxyethoxy)phenyl)-1H-indazole-3-carboxylic acid
https://huagongshe.com/reaction/338482
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | 2-(p-Bromophenoxy)ethanol | HCID 99168 | — |
| Reactant | Potassium Acetate | HCID 517044 | — |
| Reactant | Bis(neopentyl glycolato)diboron | HCID 2734316 | — |
| Reactant | 5-bromo-6-chloro-1H-indazole-3-carboxylic acid | HCID 86698791 | — |
| Catalyst | Bis(cyclopenta-1,4-dien-1-yl(diphenyl)phosphane);dichloropalladium;iron(2+) | HCID 178418228 | — |
| Solvent | Ethanol | HCID 702 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | 6-Chloro-5-(4-(2-hydroxyethoxy)phenyl)-1H-indazole-3-carboxylic acid | HCID 86698818 | 19.3% |
Reaction Steps
A suspension of 2-(4-bromophenoxy)ethanol (100 mg, 0.46 mmol), 5,5,5′,5′-tetramethyl-2,2′-bi-1,3,2-dioxaborinane (173 mg, 0.50 mmol), [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) (38.0 mg, 0.025 mmol) and potassium acetate (135 mg, 1.38 mmol) in 1,4-dioxane (1 mL) was sealed in a pressure tube and heated to 130° C. for 1 hour. To the mixture was added 5-bromo-6-chloro-1H-indazole-3-carboxylic acid (100 mg, 0.36 mmol), [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) (14.7 mg, 0.018 mmol), 2N aqueous potassium carbonate solution (0.5 mL, 1.0 mmol) and EtOH (2 mL). The mixture was sealed and heated to 130° C. for 1 hour. Water (3 mL) was added to the reaction mixture, followed by 1N HCl solution to adjust the pH to 2. The layers were separated and the aqueous layer was extracted with EtOAc (3×5 mL). The combined organic layers were dried over Na2SO4 and concentrated in vacuo. The crude material was purified by reverse phase HPLC (Column: Waters Sunfire C18 19×100 mm, 5 μm; Mobile phase A: 0.05% Formic acid in water (v/v); Mobile phase B: 0.05% Formic acid in MeCN (v/v); HOLD at 75.0% H2O/25.0% MeCN for 1.0 min. 75.0% H2O/25.0% MeCN linear to 45.0% H2O/55.0% MeCN in 6.75 min, linear to 0% H2O/100% MeCN to 7.0 min. HOLD at 0% H2O/100% MeCN from 7.0 to 8.0 min. Flow: 30 mL/min) to afford the title compound (23.1 mg, 15% yield). MS (ES+) 333.0 (M+H)+. Retention time=2.19 minutes (Column: Waters Atlantis dC18 4.6×50 mm, 5 μm; Mobile phase A: 0.05% TFA in water (v/v); Mobile phase B: 0.05% TFA in MeCN (v/v); Gradient: 95:5 A:B linear to 5:95 A:B in 4.0 min, hold at 5:95 A:B to 5.0 min. Flow: 2 mL/min).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08889730B2 |
|---|
| Source dataset | uspto-grants-2014_11 |
|---|
| ORD ID | ord-080160d3e2ae40ed82bf405b1dd6f32c |
|---|
| Source note | uspto-grants-2014_11 |
|---|